Distinct mechanisms control human naive and antigen-experienced CD8 + T lymphocyte proliferation

Journal of Immunology

Volumn 176, Issue 4, 2006, Pages 2173-2182

  Migliaccio, Marco ^a,c   Sousa Alves, Pedro Miguel ^b,c   Romero, Pedro ^b,c   Rufer, Nathalie ^a,c  

^a SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c Schweizerische Nationalfonds SNF   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; MITOGENIC AGENT; PROTEIN BCL 2; PROTEIN P16INK4A;

ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL CYCLE ARREST; CELL DEATH; CORRELATION ANALYSIS; EFFECTOR CELL; HUMAN; HUMAN CELL; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

EID: 32044452233     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.4.2173     Document Type: Article

References (47)

1. + T cells. J. Exp. Med. 186: 1407-1418.
2. Sallusto, F., D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
3. + T subsets with distinct replicative history and partial effector functions. Blood 102: 1779-1787.
4. Wells, A. D., H. Gudmundsdottir, and L. A. Turka. 1997. Following the fate of individual T cells throughout activation and clonal expansion: signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J. Clin. Invest. 100: 3173-3183.
5. Wells, A. D., M. C. Walsh, D. Sankaran, and L. A. Turka. 2000. T cell effector function and anergy avoidance are quantitatively linked to cell division. J. Immunol. 165: 2432-2443.
6. + memory T cell generation. J. Immunol. 173: 3763-3772.
7. + T lymphocytes. J. Immunol. 174: 3335-3343.
8. + T cells. J. Exp. Med. 194: 1711-1719.
9. + memory T-cell subsets in response to antigen or homeostatic cytokines. Blood 101: 4260-4266.
10. Marrack, P., and J. Kappler. 2004. Control of T cell viability. Annu. Rev. Immunol. 22: 765-787.
11. Alderson, M. R., T. W. Tough, T. Davis-Smith, S. Braddy, B. Falk, K. A. Schooley, R. G. Goodwin, C. A. Smith, F. Ramsdell, and D. H. Lynch. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181: 71-77.
12. Hildeman, D. A., Y. Zhu, T. C. Mitchell, J. Kappler, and P. Marrack. 2002. Molecular mechanisms of activated T cell death in vivo. Curr. Opin. Immunol. 14: 354-359.
13. Vander Heiden, M. G., and C. B. Thompson. 1999. Bcl-2 proteins: regulators of apoplosis or of mitochondrial homeostasis? Nat. Cell Biol. 1: E209-E216.
14. Strasser, A., A. W. Harris, and S. Cory. 1991. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67: 889-899.
15. Wei, M. C., W. X. Zong, E. H. Cheng, T. Lindsten, V. Panoulsakopoulou, A. J. Ross, K. A. Roth, G. R. MacGregor, C. B. Thompson, and S. J. Korsmeyer. 2001. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292: 727-730.
16. Hildeman, D. A., Y. Zhu, T. C. Mitchell, P. Bouillet, A. Strasser. J. Kappler, and P. Marrack. 2002. Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity 16: 759-767.
17. + T cells. J. Immunol. 164: 3950-3954.
18. + T cells that re-express CD45RA are apoptosis-resistant memory cells that retain replicative potential. Blood 100: 933-940.
19. Akbar, A. N., N. Borthwick, M. Salmon, W. Gombert, M. Bofill, N. Shamsadeen, D. Pilling, S. Pett, J. E. Grundy, and G. Janossy. 1993. The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections: the role of apoptosis in T cell memory. J. Exp. Med. 178: 427-438.
20. Grana, X., J. Garriga, and X. Mayol. 1998. Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth. Oncogene 17: 3365-3383.
21. 1 proliferative arrest. Cell Biochem. Binphys. 33: 189-197.
22. 1 that controls entry into the cell cycle. Mol. Cell. Biol. 23: 2351-2361.
23. INK4a in replicative senescence of normal human fibroblasts. Proc. Natl. Acad. Sci. USA 93: 13742-13747.
24. Ramirez, R. D., C. P. Morales, B. S. Herbert, J. M. Rohde, C. Passons, J. W. Shay, and W. E. Wright. 2001. Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev. 15: 398-403.
25. De Magalhaes, J. P., F. Chainiaux, J. Remaele, and O. Toussaint. 2002. Stress-induced premature senescence in BJ and hTERT-BJ1 human foreskin fibroblasts. FEES Lett. 523: 157-162.
26. Beausejour, C. M., A. Kriolica, F. Galimi, M. Narita, S. W. Lowe, P. Yaswen, and J. Campisi. 2003. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J. 22: 4212-4222.
27. Naka, K., A. Tachibana, K. Ikeda, and N. Motoyama. 2004. Stress-induced premature senescence in hTERT-expressing ataxia tetangiectasia fibroblasts. J. Biol. Chem. 279: 2030-2037.
28. Drexler, H. G. 1998. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Leukemia 12: 845-859.
29. Sharpless, N. E., N. Bardeesy, K. H. Lee, D. Carrasco, D. H. Castrillon, A. J. Aguirre, E. A. Wu, J. W. Horner, and R. A. DePinho. 2001. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature 413: 86-91.
30. Romero, P., P. R. Dunbar, D. Valmori, M. Pittet, G. S. Ogg, D. Rimoldi, J. L. Chen, D. Lienard, J. C. Cerottini, and V. Cerundolo. 1998. Ex vivo staining of metastatic lymph nodes by class 1 major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J. Exp. Med. 188: 1641-1650.
31. Lamers, C. H., R. J. van de Griend, E. Braakman, C. P. Ronteltap, J. Benard, G. Stoter, J. W. Gratama, and R. L. Bolhuis. 1992. Optimization of culture conditions for activation and large-scale expansion of human T lymphocytes for bispecific antibody-directed cellular immunotherapy. Int. J. Cancer 51: 973-979.
32. Shay, J. W., and I. B. Roninson. 2004. Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 23: 2919-2933.
33. Ben-Porath, I., and R. A. Weinberg. 2004. When cells get stressed: an integrative view of cellular senescence. J. Clin. Invest. 113: 8-13.
34. Douek, D. C., M. R. Betts, B. J. Hill, S. J. Little, R. Lempicki, J. A. Metcalf, J. Casazza, C. Yoder, J. W. Adelsberger, R. A. Stevens, et al. 2001. Evidence for increased T cell turnover and decreased thymic output in HIV infection. J. Immunol. 167: 6663-6668.
35. Zippelius, A., M. J. Pittet, P. Batard, N. Rufer, M. de Smedt, P. Guillaume, K. Ellefsen, D. Valmori, D. Lienard, J. Plum, et al. 2002. Thymic selection generates a large T cell pool recognizing a self-peptide in humans. J. Exp. Med. 195: 485-494.
36. Cheng, N., Y. M. Janumyan, L. Didion, C. Van Hofwegen, E. Yang, and C. M. Knudson. 2004. Bcl-2 inhibition of T-cell proliferation is related to prolonged T-cell survival. Oncogene 23: 3770-3780.
37. Freitas, A. A., and B. Rocha. 2000. Population biology of lymphocytes: the flight for survival. Annu. Rev. Immunol. 18: 83-111.
38. - immature thymocytes. J. Immunol. 168: 2325-2331.
39. Veiga-Fernandes, H., and B. Rocha. 2004. High expression of active CDK6 in the cytoplasm of CD8 memory cells favors rapid division. Nat. Immunol 5: 31-37.
40. Kaech, S. M., S. Hemby, E. Kersh, and R. Ahmed. 2002. Molecular and functional profiling of memory CD8 T cell differentiation. Cell 111: 837-851.
41. + T cells. J. Virol. 78: 10953-10959.
42. Gett, A. V., F. Sallusto, A. Lanzavecchia, and J. Geginat. 2003. T cell fitness determined by signal strength. Nat. Immunol. 4: 355-360.
43. Hayflick, L., and P. S. Moorhead. 1961. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25: 585-621.
44. Narita, M., S. Nunez, E. Heard, A. W. Lin, S. A. Hearn, D. L. Spector, G. J. Hannon, and S. W. Lowe. 2003. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113: 703-716.
45. Schmitt, C. A., J. S. Fridman, M. Yang, S. Lee, E. Baranov, R. M. Hoffman, and S. W. Lowe. 2002. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109: 335-346.
46. Maus, M. V., B. Kovacs, W. W. Kwok, G. T. Nepom, K. Schlienger, J. L. Riley, D. Allman, T. H. Finkel, and C. H. June. 2004. Extensive replicative capacity of human central memory T cells. J. Immunol. 172: 6675-6683.
47. Bianchi, T., N. Rufer, R. H. MacDonald, and M. Migliaccio. The tumor suppressor p16Ink4a regulales T lymphocyte survival. Oncogene. In press.